Moderna
MRNA
#1944
Rank
C$13.89 B
Marketcap
C$35.56
Share price
1.27%
Change (1 day)
-39.30%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: C$13.89 Billion

As of December 2025 Moderna has a market cap of C$13.89 Billion. This makes Moderna the world's 1944th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025C$13.89 B-37.29%
2024C$22.16 B-55.94%
2023C$50.29 B-46.29%
2022C$93.63 B-28.65%
2021C$131.23 B148.97%
2020C$52.71 B513.11%
2019C$8.59 B25.71%
2018C$6.83 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Moderna was reported to be:

C$13.89 Billion
by Nasdaq info icon info icon
C$13.89 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
C$0.78 B-94.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$351.59 B 2,430.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
C$1.16 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$85.77 B 517.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$354.53 B 2,451.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
C$12.47 B-10.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$680.64 B 4,798.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
C$4.15 B-70.10%๐Ÿ‡บ๐Ÿ‡ธ USA